BiotechTube

Tedizolid phosphate + Linezolid

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Pneumonia

Conditions

Pneumonia

Trial Timeline

Jan 6, 2014 → Jun 22, 2018

NCT ID
NCT02019420

About Tedizolid phosphate + Linezolid

Tedizolid phosphate + Linezolid is a phase 3 stage product being developed by Merck for Pneumonia. The current trial status is completed. This product is registered under clinical trial identifier NCT02019420. Target conditions include Pneumonia.

What happened to similar drugs?

20 of 20 similar drugs in Pneumonia were approved

Approved (20) Terminated (4) Active (0)
✅doripenemJohnson & JohnsonApproved
✅Simultaneous administration of Pneumovax NP® and Fluvic HA syringe® + Sequential administration of Pneumovax NP® and Fluvic HA syringe®MerckApproved
✅Imipenem + ImipenemMerckApproved
✅Ceftolozane / Tazobactam InjectionMerckApproved
✅ceftriaxoneRocheApproved
✅Zavicefta, Ceftazidime-AvibactamPfizerApproved
✅Vancomycin + LinezolidPfizerApproved

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT02019420Phase 3Completed

Competing Products

20 competing products in Pneumonia

See all competitors
ProductCompanyStageHype Score
CAL02 Low-dose + CAL02 High-dose + PlaceboCombioxinPhase 1
19
tacrolimusAstellas PharmaPre-clinical
26
Cefiderocol + Best Available TherapyShionogiPhase 3
40
Cefiderocol + Meropenem + LinezolidShionogiPhase 3
40
Cefiderocol + Standard of Care AntibioticShionogiPhase 1
21
ONO-5046Na + ONO-5046NaOno PharmaceuticalPhase 2
35
doripenemJohnson & JohnsonApproved
43
levofloxacin; imipenem/cilastitinJohnson & JohnsonPhase 3
40
levofloxacinJohnson & JohnsonPhase 3
40
levofloxacinJohnson & JohnsonPhase 2/3
38
LevofloxacinJohnson & JohnsonPhase 3
40
doripenemJohnson & JohnsonPhase 3
40
doripenemJohnson & JohnsonPhase 3
40
Doripenem + Imipenem-Cilastatin + PlaceboJohnson & JohnsonPhase 3
32
Imipenem/cilastatin + Imipenem/cilastatin + Doripenem + DoripenemJohnson & JohnsonPhase 2
35
HRS-8427 + MeropenemJiangsu Hengrui MedicinePhase 2
42
Ceftazidime-avibactamAbbViePhase 1
21
Ticagrelor + PlaceboAstraZenecaPhase 2
27
Ceftolozane/Tazobactam + Piperacillin/TazobactamMerckPhase 3
32
IMI/REL FDC + PIP/TAZ FDC + LinezolidMerckPhase 3
40